Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug release

Biomaterials

Volumn 27, Issue 2, 2006, Pages 262-270

  Zhang, Zhiping ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biodegradable polymers; Cancer nanotechnology; Chemotherapy; Paclitaxel; Taxol

Indexed keywords

CHEMOTHERAPY; NANOSTRUCTURED MATERIALS; POLYETHYLENE GLYCOLS; SCANNING ELECTRON MICROSCOPY; SOLVENT EXTRACTION; TUMORS; X RAY PHOTOELECTRON SPECTROSCOPY;

BIODEGRADABLE POLYMERS; CANCER NANOTECHNOLOGY; PACLITAXEL; TAXOL®;

COPOLYMERS;

ALPHA TOCOPHEROL; COPOLYMER; NANOPARTICLE; PACLITAXEL; POLYLACTIDE; POLYLACTIDE ALPHA TOCOPHEROL POLYETHYLENE GLYCOL 1000 SUCCINATE; TOCOFERSOLAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; EVAPORATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NANOTECHNOLOGY; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLVENT EXTRACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG CARRIERS; DRUG THERAPY; HUMANS; LACTIC ACID; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NANOSTRUCTURES; NEOPLASMS; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; SURFACE PROPERTIES; VITAMIN E;

EID: 24644459310     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2005.05.104     Document Type: Article

References (25)

1. S.S. Feng, and G.F. Huang Effects of emulsifiers on the controlled release of paclitaxel (Taxol (R)) from nanospheres of biodegradable polymers J Control Release 71 2001 53 69
2. L. Mu, and S.S. Feng Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol (R)) J Control Release 80 2002 129 144
3. L. Mu, and S.S. Feng PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio Pharm Res 20 2003 1864 1872
4. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R)): PLGA nanoparticles containing vitamin E TPGS J Control Release 86 2003 33 48
5. S.S. Feng, L. Mu, B.H. Chen, and D. Pack Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol((R))) Mater Sci Eng C-Biomimetic Supramol Syst 20 2002 85 92
6. J.R. Fischer, K.R. Harkin, and L.C. Freeman Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine A in healthy dogs Vet Tech: Res Appl Vet Med 3 2002 465 473
7. J.M. Dintaman, and J.A. Silverman Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm Res 16 1999 1550 1556
8. L. Yu, A. Bridgers, and J. Polli Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability Pharm Res 16 1999 1812 1817
9. H. Gelderblom, J. Verweij, and K. Nooter Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur J Cancer 37 13 2001 1590 1598
10. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int J Pharm 235 1-2 2002 179 192
11. R.T. Dorr Pharmacology and toxicology of Cremophor EL diluent Ann Pharmacother 28 1994 S11 S14
12. M.L. Fjallskog, L. Frii, and J. Bergh Is Cremophor El, Solvent for Paclitaxel, Cytotoxic Lancet 342 1993 873
13. R.B. Weiss, R.C. Donehower, and P.H. Wiernik Hypersensitivity Reactions from Taxol J Clin Oncol 8 1990 1263 1268
14. J.C. Ha, S.Y. Kim, and Y.M. Lee Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres - I. Preparation and characterization J Control Release 62 1999 381 392
15. T. Mosmann Rapid calorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assay J Immunol Methods 65 1983 55 63
16. J. Neuzil Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity Br J Cancer 89 2003 1822 1826
17. M. Birringer, J.H. EyTina, B.A. Salvatore, and J. Neuzil Vitamin E analogues as inducers of apoptosis: structure-function relation Br J Cancer 88 2003 1948 1955
18. K.I. Momot, P.W. Kuchel, and B.E. Chapman NMR study of the association of propofol with nonionic surfactants Langmuir 19 2003 2088 2095
19. H. Schroder, and T. Netscher Determination of the absolute stereochemistry of vitamin E derived oxa-spiro compounds by NMR spectroscopy Magn Reson Chem 39 2001 701 708
20. K.Y. Win, and S.S. Feng Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs Biomaterials 26 2005 2713 2722
21. R. Savic, L.B. Luo, A. Eisenberg, and D. Maysinger Micellar nanocontainers distribute to defined cytoplasmic organelles Science 300 2003 615 618
22. L.B. Luo, J. Tam, D. Maysinger, and A. Eisenberg Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles Bioconjugate Chem 13 2002 1259 1265
23. M.E. Lefevre, J.W. Vanderhoff, J.A. LaIssue, and D.D. Joel Accumulation of 2-micron latex particles in mouse Peyer's patches during chronic latex feeding Experimentia 34 1978 120 122
24. Y.C. Dong, and S.S. Feng Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs Biomaterials 25 2004 2843 2849
25. K.Y. Cho, S.H. Choi, and C.H. Kim Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(L-lactide) J Control Release 76 2001 275 284